Health care-associated acute pyelonephritis is associated with inappropriate empiric antibiotic therapy in the ED.

[1]  A. Schaeffer,et al.  CLINICAL PRACTICE. Urinary Tract Infections in Older Men. , 2016, The New England journal of medicine.

[2]  A. Gardner,et al.  Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies , 2015, BMC Infectious Diseases.

[3]  A. Mert,et al.  Comparison of community‐onset healthcare‐associated and hospital‐acquired urinary infections caused by extended‐spectrum beta‐lactamase‐producing Escherichia coli and antimicrobial activities , 2015, International journal of clinical practice.

[4]  S. Wie,et al.  A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis , 2015, The Korean journal of internal medicine.

[5]  S. Park,et al.  Impact of Extended-Spectrum β-Lactamase Production on Treatment Outcomes of Acute Pyelonephritis Caused by Escherichia coli in Patients without Health Care-Associated Risk Factors , 2015, Antimicrobial Agents and Chemotherapy.

[6]  W. Gi,et al.  Prognostic determinants of community-acquired bloodstream infection in type 2 diabetic patients in ED. , 2014, The American journal of emergency medicine.

[7]  K. Kwon,et al.  Clinical characteristics predicting early clinical failure after 72 h of antibiotic treatment in women with community-onset acute pyelonephritis: a prospective multicentre study. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  Young Keun Kim,et al.  Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[9]  A. Schaeffer,et al.  Management of non-catheter-associated complicated urinary tract infection. , 2014, Infectious disease clinics of North America.

[10]  S. Cho,et al.  Impact of extended-spectrum beta-lactamase on acute pyelonephritis treated with empirical ceftriaxone. , 2014, Microbial drug resistance.

[11]  J. Rodríguez-Baño,et al.  Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  Wonkeun Song,et al.  Strategies for Interpretive Standards of β-Lactams Susceptibility Testing and Identification of Extended-Spectrum β-Lactamases and Carbapenemases in Enterobacteriaceae , 2013 .

[13]  S. Richter,et al.  Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  N. Oztoprak,et al.  Inadequate treatment of ventilator-associated and hospital-acquired pneumonia: Risk factors and impact on outcomes , 2012, BMC Infectious Diseases.

[15]  J. Horcajada,et al.  Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections. , 2012, Journal of Infection.

[16]  Jieun Kim,et al.  Fluoroquinolone resistance in uncomplicated acute pyelonephritis: epidemiology and clinical impact. , 2012, Microbial drug resistance.

[17]  T. Hooton.  Clinical practice. Uncomplicated urinary tract infection. , 2012, The New England journal of medicine.

[18]  N. Kim,et al.  Empirical Use of Ciprofloxacin for Acute Uncomplicated Pyelonephritis Caused by Escherichia coli in Communities Where the Prevalence of Fluoroquinolone Resistance Is High , 2012, Antimicrobial Agents and Chemotherapy.

[19]  G. Kahlmeter,et al.  Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. , 2012, International journal of antimicrobial agents.

[20]  Kamaljit Singh,et al.  High rates of quinolone resistance among urinary tract infections in the ED. , 2012, The American journal of emergency medicine.

[21]  K. Peck,et al.  Clinical implications of healthcare-associated infection in patients with community-onset acute pyelonephritis , 2011, Scandinavian journal of infectious diseases.

[22]  C. van Nieuwkoop,et al.  Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection. , 2011, The Journal of antimicrobial chemotherapy.

[23]  D. Chung,et al.  Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis. , 2011, The Journal of infection.

[24]  Sanjay Saint,et al.  Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  J. Pitout.  Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae , 2010, Drugs.

[26]  E. Erdfelder,et al.  Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses , 2009, Behavior research methods.

[27]  Y. Tabak,et al.  Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database* , 2006, Critical care medicine.

[28]  M. Niederman,et al.  Appropriateness and delay to initiate therapy in ventilator-associated pneumonia , 2006, European Respiratory Journal.

[29]  Marin H Kollef,et al.  Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. , 2005, Chest.

[30]  D. Panagiotakos,et al.  Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.

[32]  S. Toledo,et al.  Infections in elderly persons. An altered clinical presentation. , 1992, Clinics in geriatric medicine.

[33]  R. Rubin,et al.  An approach to evaluating antibacterial agents in the treatment of urinary tract infection. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.